Abstract:Abstract BAP1 tumour predisposition syndrome (BAP1-TPDS) is a newly recognized cancer syndrome that predisposes patients to uveal melanoma, malignant mesothelioma, renal cell carcinoma, cutaneous melanomas and an emerging range of other cancers. We previously presented a 48-year-old patient with an isolated melanoma metastasis on his wrist arising on a background of a germline BAP1 mutation. We wish to provide an update on his diagnosis, which has been revised to a malignant peripheral nerve sheath tumour (MPNST). To our knowledge, there is only one published similar case in a patient with BAP1-TPDS (Kaszuba MC, Pulido JS, Folpe AL et al. Malignant peripheral nerve sheath tumor in a patient with BAP1 tumor predisposition syndrome. World Neurosurg 2018; 109: 362–4). The patient initially presented to the hand surgeons with a 5-year history of a subcutaneous swelling on his right wrist associated with paraesthesia and pain. Excision biopsy of the lesion revealed a perineural encapsulated pleomorphic tumour with large atypical cells and small neurofibroma-appearing cells at the periphery. Immunohistochemistry showed expression of S100, SOX10 and calretinin, and negative melan-A. Next-generation sequencing revealed BAP1 loss with high variant allele frequency. The patient’s mother died from metastatic uveal melanoma, his maternal grandmother had a history of mesothelioma and his aunt died of a brain tumour. Germline testing showed the patient to be heterozygous for the pathogenic BAP1 sequence variant c.122+1del. We initially presented this case as a stage IV metastatic melanoma deposit on the right wrist originating from a pT4a BAP1 inactivated primary melanoma on the back. This skin lesion had been present for 10 years without change and there was no visceral organ involvement. Due to the unusual nature of the presentation further input from a specialist skin cancer multidisciplinary team with an interest in BAP1-TPDS led to a revised diagnosis of an MPNST on the wrist. The primary melanoma diagnosis was changed to a low-risk BAP1 melanocytoma, based on histological and immunohistochemical findings. Two other low-risk melanocytomas were also excised. The patient was referred to the sarcoma multidisciplinary team, for wide local excision of the MPNST, staging scans and surveillance, including annual ophthalmology review, dermatology review and renal imaging. BAP1 loss in MPNST has only been described once before, interestingly with a splice receptor germline disease-causing variant (Kaszuba et al.). Our case highlights the potential diagnostic complexity associated with BAP1-TPDS for the dermatologist and dermatopathologist. Clinicians should be aware of the proposed surveillance guidelines, while being mindful that the spectrum of associated cancers is expanding. For complex cases like ours, gaining input from centres with experience managing patients with BAP1-TPDS can refine the diagnosis, with important implications for prognosis and patient outcomes.

BRCA1‐associated protein 1: Tumor predisposition syndrome and Kury‐Isidor syndrome, from genotype–phenotype correlation to clinical management

Common, Germline Genetic Variations in the Novel Tumor Suppressor Bap1 and Risk of Developing Different Types of Cancer

A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma.

The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK

Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico

CPC12 A metastatic melanoma mimic: malignant peripheral nerve sheath tumour in the setting of a rare germline BAP1 disease-causing variant

POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program

Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series

EP1.03-17 Outcomes of Molecular Characteristics in Chinese BAP1-Mutant Non-Small Cell Lung Cancer Patients

Tissue-specific Significance of BAP1 Gene Mutation in Prognostic Prediction and Molecular Taxonomy among Different Types of Cancer.

HAP1 cell utilization for accurate interpretation of germline BAP1 variants

Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations

The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effect

Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels

MUTYH-related polyposis syndrome associated with a variant of uncertain significance mutation: A new pathogenic mutation?

Loss of BAP1 Results in Growth Inhibition and Enhances Mesenchymal-Epithelial Transition in Kidney Tumor Cells.

Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome

BRCA1-associated Protein 1 Serves As a Tumor Suppressor in Hepatocellular Carcinoma by Deubiquitinating and Stabilizing PTEN.

Abstract PR09: Functional and clinical characterization of hypomorphic missense variants in the BRCA2 cancer predisposition gene

Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation